SUPPRESS-NSCLC · Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer
Trial terminated
Also in this update: Final enrollment: 52 participants (planned 68); Primary completion date changed from estimate of Dec 1, 2026 to Jan 6, 2026
Centre hospitalier de l'Université de Montréal (CHUM)Phase 2 NCT04405401 Registry history of NCT04405401 on ClinicalTrials.gov (opens the registry)